Please login to the form below
drug treatment
This page shows the latest drug treatment news and features for those working in and with pharma, biotech and healthcare.
Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
The antibody drug treatment has thus far only been authorised for emergency use by the FDA to treat COVID-19 in specific emergency cases in non-hospital settings. ... Bebtelovimab has not been approved, but has been given an Emergency Use Authorisation
Latest news
-
FDA issues innovative proposal to increase nonprescription drug access
If finalised, the proposed rule would require drug companies to include an additional condition for nonprescription use when submitting a new application to bring a nonprescription drug treatment to market. ... Under the proposed rule, when the FDA finds
-
Bristol Myers Squibb announces positive trial results for treatment of MS
Zeposia was initially approved by the US Food and Drug Administration (FDA) for the treatment of relapsing forms of MS in March 2020, while the European Commission also authorised the drug ... for the treatment of adult patients with relapsing remitting
-
Shionogi and F2G partner to develop antifungal treatment olorofim
The deal, worth up to $480m, involves the first novel antifungal treatment developed in the last 20 years. ... It also covers azole-resistant strains, coccidioidomycosis and scedosporiosis (including lomentosporiosis). The treatment has already been
-
BioXcel Therapeutics begins phase 3 trial for acute agitation in Alzheimer’s patients
There are no approved treatment options available for acute agitation related to dementia. ... BXCL501 was granted an earlier Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for the acute treatment of agitation in dementia,
-
FDA approves COVID-19 treatment for those under the age of 12
Veklury is currently the only COVID-19 treatment approved for this age group. ... For hospitalised patients who do not require invasive mechanical ventilation and/or ECMO, a five-day treatment course is recommended.
More from news
Approximately 2 fully matching, plus 976 partially matching documents found.
Latest Intelligence
-
The promise of precision medicine
treatment. The world- class Sidra Medicine hospital and the Qatar Biomedical Research Institute are using genomes to identify personalised lifestyle interventions to tackle obesity. ... of the right drug treatment for the individual.
-
Rare genetic diseases – what’s in store for 2021?
In 2021 we can expect more clinical studies that produce meaningful data, more advanced research and an increase in drug approvals that offer truly innovative treatment options. ... We’re looking at digital advances that would improve access to
-
The search for effective drug treatments for COVID-19
to find an effective drug treatment for patients and the journey of remdesivir that began a decade ago as part of Gilead’s emerging viruses programme. ... The World Health Organization (WHO) has not included Gilead’s antiviral treatment remdesivir in
-
Time to tear down the wallpaper?
treatment or breakthrough drug?
-
AI: the smart money is on the smart thinking
This influx of capital means there are already close to 200 start-ups using AI in drug discovery. ... Take, for example, the case of baricitinib, originally an Eli Lilly rheumatoid arthritis drug, now repurposed as a promising treatment for COVID-19.
More from intelligence
Approximately 0 fully matching, plus 50 partially matching documents found.
Latest appointments
-
Finland's Faron Pharmaceuticals appoints new medical director
In his new role he will join Turku-based Faron's executive management team and oversee its drug development strategy, including its clinical programmes for Traumakine and Clevegen. ... Our lead drug candidate Traumakine, for the treatment of Acute
-
Canbex hires former Lilly medical director
As chief medical officer at Canbex Dr Lledó will lead preparations for proof of concept trials for the company's lead candidate VSN16R, an oral drug intended for the treatment of ... As a practicing neurologist and experienced drug developer, I am very
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
What does the future hold for clinical trial recruitment?
Drug trials are often competing with each other as pharmaceutical rivals race to be the first to develop a drug or treatment. ... treatment and one they would wish to be aware of so they have the chance to participate.
-
Onyx Health Joins Forces with Rare Disease Specialists Actigen
The current focus of Actigen's work is on the development of a drug for a potential breakthrough treatment for the life-limiting rare disease known as MPS II or Hunter ... There are 6, 000 rare diseases affecting approximately 300 million people worldwide
-
Improving healthcare for rare disease patients
There is only a very small target market, meaning that the company developing the treatment would find it difficult to cover the development costs of a new drug, while also keeping ... In February this year, it was announced that the world’s most
-
THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide
The campaign shares their unique reasons for carrying naloxone, a drug that they now all carry. ... pharmacies and drug treatment centres, ensuring the lifesaving message reaches the people who need to see it.
-
How a design mindset can lead to better medical outcomes
When this starts earlier in the development process, it proves to be hugely beneficial in demonstrating the tangible value to the patient of the drug or treatment, the support structure surrounding ... Understanding the patient. Exactly how this
More from PMHub
Approximately 0 fully matching, plus 16 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
